The U.S. House of Representatives is set to focus on countering China's influence and power through various sectors such as biotech companies, drones, and electric vehicles as lawmakers return from their summer break. The legislation being considered aims to ensure U.S. competitiveness in the face of China's growing global presence. With bipartisan support, many bills scheduled for a vote this week underscore the consensus that congressional action is necessary to address the challenge posed by China.
One of the key bills aims to restrict U.S. reliance on Chinese biotech companies by banning specific entities with Chinese ties from collaborating with recipients of federal funding. This move is intended to safeguard U.S. healthcare data and reduce dependency on China for medical supplies and services.
